You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Germany

Jul 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer health overall stagnating in Germany in 2011

In Germany in 2011, retail value sales of consumer health products saw development stagnate, with mixed performances from various products. While there was growth seen in products such as medicated skin care, this was offset by stagnant performance for the likes of analgesics and decline of products such as vitamins and dietary supplements. Compared to the review period as a whole, development in 2011 was slightly below average, mainly because 2007 and 2009 had each seen small growth.

Market under pressure from healthier diets and more exercise

In line with the ongoing or even intensifying health and wellness trend in Germany, more people are turning towards healthier diets on the one hand and/or towards more physical exercise on the other hand, which both mean that Germans are falling ill less frequently on average and therefore purchasing fewer OTC medications. Vitamins and dietary supplements however suffered from negative media coverage about their effects or even their potential dangers.

Very fragmented market continues to be led by Bayer Vital

Compared to other markets, consumer health continues to be very fragmented in Germany in terms of the competitive environment, with even the largest players commanding shares of only around 5%. The leading players were all consumer healthcare subdivisions of multinationals, notably Bayer, Johnson & Johnson, Novartis and GlaxoSmithKline.

Consumer healthcare most often sold in health and beauty retailers

The largest channels by far in terms of the retailing environment remain chemists/pharmacies and parapharmacies/drugstores, which accounted for three fifths and one fifth of all consumer health value sales, respectively, in Germany in 2011. The most successful channel however, with a constantly rising share of sales is internet retailing. Online retailers are also expected to show substantial growth over the forecast period.

Small decline of consumer health expected over forecast period in Germany

Over the forecast period, total retail value sales of consumer health are expected to see a small annual decline in constant terms, due to lack of growth opportunities on the one hand and continued strong competition from other areas, such as healthier diets, products with health benefits – such as fortified/functional products - as well as increased exercise and therefore better health of the population on the other hand.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Germany with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Germany, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Germany for free:

The Consumer Health in Germany market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Germany?
  • What are the major brands in Germany?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Germany - Industry Overview

EXECUTIVE SUMMARY

Consumer health overall stagnating in Germany in 2011

Market under pressure from healthier diets and more exercise

Very fragmented market continues to be led by Bayer Vital

Consumer healthcare most often sold in health and beauty retailers

Small decline of consumer health expected over forecast period in Germany

KEY TRENDS AND DEVELOPMENTS

Ongoing relatively favourable economic conditions in Germany in 2011

Demographic changes continue to influence consumer health in Germany

Increasing shares of sales through internet retailing in consumer health

Consumer lifestyle issues offer opportunities for manufacturers and retailers

Innovation essential for premium brands to thrive in consumer health

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Switches

  • Summary 1 OTC - Switches 2010-2011

DEFINITIONS

SOURCES

  • Summary 2 Research Sources

Consumer Health in Germany - Company Profiles

Bayer Vital GmbH in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 5 Bayer Vital GmbH: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 6 Bayer Vital GmbH: Competitive Position 2011

GlaxoSmithKline GmbH & Co KG in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 9 GlaxoSmithKline GmbH & Co KG: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 10 GlaxoSmithKline GmbH & Co KG: Competitive Position 2011

Hartmann AG, Paul in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Paul Hartmann AG: Competitive Position 2011

Hexal AG in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 16 Hexal AG: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 17 Hexal AG: Competitive Position 2011

Johnson & Johnson GmbH in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 20 Johnson & Johnson GmbH: Competitive Position 2011

Mann Chem-Pharm Fabrik GmbH, Dr Gerhard in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 23 Mann Chem-Pharm Fabrik GmbH, Dr Gerhard: Competitive Position 2011

MCM Klosterfrau Vertriebsgesellschaft mbH in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 26 MCM Klosterfrau Vertriebsgesellschaft mbH: Competitive Position 2011

Novartis Consumer Health GmbH in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 29 Novartis Deutschland GmbH: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 30 Novartis Consumer Health GmbH: Competitive Position 2011

Ratiopharm GmbH & Co in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 33 Ratiopharm GmbH & Co: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 34 Ratiopharm GmbH & Co: Competitive Position 2011

STADA Arzneimittel AG in Consumer Health (Germany)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 37 STADA Arzneimittel AG: Competitive Position 2011

Adult Mouth Care in Germany - Category Analysis

HEADLINES

TRENDS

  • In 2011, retail value sales of OTC adult mouth care products in Germany are expected to decline by 2% to almost €72 million, the fourth year in a row showing negative development. The reason for the decline is the constantly improved oral hygiene. The high cost of dental treatment, which to an increasing degree is usually not covered by the health insurance system, is a strong incentive for people to maintain good oral hygiene and avoid the high cost of visits to the dentist.

SWITCHES

COMPETITIVE LANDSCAPE

  • With GlaxoSmithKline GmbH & Co KG, Rottapharm Madaus GmbH, Johnson & Johnson GmbH and Viatris GmbH & Co KG, the category has four players holding a double-digit share of total value sales in 2011. Among those consumers interested in the category and regularly buying such products, these companies and their brands enjoy good awareness and reputation, resulting in relatively high loyalty to the products used. In addition, their products enjoy nationwide distribution through pharmacies.

PROSPECTS

  • Over the forecast period, retail value sales of OTC adult mouth care products are expected to decline by over 1% annually on average in constant terms. 2016 constant sales therefore are predicted to be at €66 million, down €5.5 million compared to 2011. German consumers will increasingly use mouth hygiene products with medicinal properties, which are a threat to sales of adult mouth care products.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 15 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Germany - Category Analysis

HEADLINES

TRENDS

  • As in previous years, within overall retail value sales of analgesics, a trend away from systemic towards topical was seen in Germany in 2011. There were many factors behind the overall decline in systemic analgesics, for example recent restrictions on self-medication pack sizes as well as consumers’ reluctance to treat minor pains with systemic analgesics, while topical analgesics were able to benefit from their growing target group of older users.

SWITCHES

COMPETITIVE LANDSCAPE

  • The top players in analgesics in Germany in 2011 continued to be Bayer Vital GmbH, Novartis Consumer Health GmbH (both with a double-digit share of overall category retail value sales), Ratiopharm GmbH & Co, Johnson & Johnson GmbH, Beiersdorf AG, Dr Theiss Naturwaren GmbH and Boehringer Ingelheim Pharma GmbH & Co KG (all with shares of between 5% and 8%). All these companies have well-known and popular products in their portfolios.

PROSPECTS

  • Over the forecast period, retail value sales of analgesics are expected to decline by around 1% annually in constant terms, such that sales in 2016 are expected to reach €755 million, down €34 million compared to 2011. A number of reasons are responsible for this likely development, most notably higher product efficacy (smaller quantities need to be consumed), as well as a significant proportion of consumers trying to find alternative methods of treatment.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 21 Analgesics Company Shares by Value 2007-2011
  • Table 22 Analgesics Brand Shares by Value 2008-2011
  • Table 23 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Germany - Category Analysis

HEADLINES

TRENDS

  • OTC calming and sleeping products were able to grow in Germany for the second year in a row in 2011, by almost 2% to reach €199 million. A large and, according to industry experts, still growing proportion of the population suffers from sleeping disorders and high stress levels due to work, family or finance related worries, and as long as these disorders are of minor dimension only, try to counteract them by using OTC calming and sleeping products.

SWITCHES

COMPETITIVE LANDSCAPE

  • No fewer than 10 companies were able to achieve a share of over 5% in terms of the category’s overall retail value sales in Germany in 2011, indicating the rather fragmented nature of this category. In addition, the presence of large parapharmacy retailers such as Dirk Rossmann KG in this top 10 list through their private label brands indicates the maturity of the category.

PROSPECTS

  • Over the forecast period, retail value sales of calming and sleeping products are expected to rise by a small degree annually in constant terms. In 2016, sales are predicted to reach €202 million, marking an increase of just €3 million in constant terms. Overall, sales therefore are expected to be quite stable due to steady demand among the German population for such products. This of course means that the forecast data have been significantly restated compared to last year’s edition from 12 months ago, when the turnaround of the category in 2010 had not been anticipated. The fear of addiction and dependence has clearly declined, especially in terms of herbal/traditional products.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2006-2011
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 27 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 28 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Germany - Category Analysis

HEADLINES

TRENDS

  • Due to growing prescription sales for cough, cold and allergy (hay fever) remedies in Germany, the overall development of OTC value sales continued to be negative. Also, in comparison to other OTC categories, the market for cough, cold and allergy remedies continued to be dependent to a much higher degree on environmental conditions such as climate and seasonal change, the spread of pollen and flu, as well as urban pollution, which also were not in favour of OTC sales in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Cough, cold and allergy remedies sales come from three main products: medicated confectionery, oral decongestants and cough remedies. With leadership of medicated confectionery and a leading position in coug remedies, MCM Klosterfrau Vertriebsgesellschaft mbH managed to emerge as the leader of overall cough, cold and allergy remedies. Meanwhile, the rest of the competition is relatively fragmented, with no other company managing to have double-digit value share up to 2011.

PROSPECTS

  • Over the forecast period, retail value sales of cough, cold and allergy remedies are expected to decline by just under 1% annually in constant terms, translating to a decline of €54 million in absolute constant value terms over 2011-2016. Due to the high interdependence between cough, cold and allergy remedies and climatic conditions in any given year, reliable forecasts regarding market development are rendered impossible. Certain trends, however, can be discerned, such as a general tendency towards milder winters and hot, dry summers, which curb cough and cold remedies sales, while early springs lengthen the pollen season and thus act as a catalyst for sales of allergy remedies. With the prevailing trend towards warmer winters, it is likely that over the long run sales volumes in cough, cold and allergy (hay fever) remedies will tend towards decline.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 33 Sales of Decongestants by Category: Value 2006-2011
  • Table 34 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 36 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Germany - Category Analysis

HEADLINES

TRENDS

  • Due to the lack of growth opportunities, the category of digestive remedies in Germany continued to decline overall in 2011, affecting all subcategories with the exception of proton pump. In the context of the economic recovery, the number of people demanding such products declined: during the global economic and financial crisis and the subsequent recession, many consumers with stress-related symptoms due to growing pressures in the workplace were forced to seek solace in OTC products more frequently in order to treat the digestive ailments that resulted from the demands imposed upon them.

SWITCHES

COMPETITIVE LANDSCAPE

  • Compared to most other categories of OTC products in Germany, digestive remedies is less fragmented, evidenced by the fact that the three largest players together (Boehringer Ingelheim Pharma GmbH & Co KG, Bayer Vital GmbH and Johnson & Johnson GmbH) were responsible for some 49% of total category retail value sales in 2011. All three top players were present with strong, popular brands, which consumers trust due to their proven effectiveness.

PROSPECTS

  • Over the forecast period, retail value sales of digestive remedies are expected to decline by almost 2% annually on average (in constant terms). In 2016, overall sales are expected to reach €458 million, around €36 million lower than in 2011 (in constant value terms). The main reason for this decline is likely to be German consumers’ continuous attempts to improve their eating habits. The health and wellness trend is having a positive impact on consumers’ digestive systems.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 43 Digestive Remedies Company Shares by Value 2007-2011
  • Table 44 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Germany - Category Analysis

HEADLINES

TRENDS

  • Most Germans continue not to use the products of the category, as they either only clean their ears with cotton buds, or in more serious cases immediately visit a doctor, and are not confident to treat such problems with OTC products. However, in 2011 the category continued to grow in Germany, following excellent development in 2010. According to industry experts, rather than winning new users for the category, this was caused by increased usage among existing category users.

SWITCHES

COMPETITIVE LANDSCAPE

  • There were four players with double-digit shares of total retail value sales in ear care in Germany in 2011, namely Südmedica GmbH, Laboratoires Diepharmex SA, Mundipharma GmbH and Norgine GmbH. Among those consumers interested in the category, these companies and their brands enjoy good awareness and reputation, resulting in a rather high loyalty to the products used. In addition, their products enjoy nationwide distribution through pharmacies.

PROSPECTS

  • OTC ear care products are expected to continue to see a small annual increase in constant value terms over the forecast period, increasing total sales from €27 million in 2011 to €28 million in 2016. In current terms, this increase is likely to be somewhat larger. Existing consumers will continue to use the products of the category to the same or even an increased degree, and manufacturers and retailers alike are expected to inform other consumers about the benefits of such products, especially with activities at the point of sale.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2006-2011
  • Table 48 Sales of Ear Care: % Value Growth 2006-2011
  • Table 49 Ear Care Company Shares by Value 2007-2011
  • Table 50 Ear Care Brand Shares by Value 2008-2011
  • Table 51 Forecast Sales of Ear Care: Value 2011-2016
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2011-2016

Eye Care in Germany - Category Analysis

HEADLINES

TRENDS

  • Retail value sales of OTC eye care products are set to grow by between 3-4% in Germany in 2011 to reach €139 million overall. Factors in favour of the category’s development are increasingly long working hours, dry air in living spaces caused by air conditioning and heating as well as polluted air, especially in cities. All these lead to an increased incidence of red eye and dry eye among German consumers; conditions that are increasingly treated with OTC eye care products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Dr Gerhard Mann Chem-Pharm Fabrik GmbH remained the largest player in OTC eye care products in Germany by far, with a value share of over 41%, followed by Johnson & Johnson GmbH, Pharm-Allergan GmbH and Ursapharm Arzneimittel GmbH & Co KG, all with shares of between 9-12% of total category value sales. Consumers demand a high level of trust and confidence in such products, which only leading companies with comparatively large advertising budgets are able to generate through brand building.

PROSPECTS

  • Over the forecast period, retail value sales of OTC eye care products in Germany are expected to grow by just under 1% annually on. None of the factors that had a positive impact on the category’s sales during the review period is expected to become significantly weaker or subside during the forecast period. On the contrary, working hours continue to lengthen rather than shorten, allergies continue to be on the rise and pollution is also not expected to decline significantly in the forecast period.

CATEGORY DATA

  • Table 53 Sales of Eye Care by Category: Value 2006-2011
  • Table 54 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 55 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 56 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 57 Eye Care Company Shares by Value 2007-2011
  • Table 58 Eye Care Brand Shares by Value 2008-2011
  • Table 59 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 60 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Germany - Category Analysis

HEADLINES

TRENDS

  • In Germany in 2011, retail value sales of herbal/traditional products in Germany declined by between 1-2% to €1,528 million. The main reason for this is the competition from the currently much more successful homoeopathic remedies (excluded from Euromonitor International’s definition of consumer health and herbal/traditional products). Homoeopathic remedies received, especially towards the end of the review period, considerable largely positive media coverage and thus were able to grow significantly in Germany.

COMPETITIVE LANDSCAPE

  • Herbal/traditional products in Germany continued to be very fragmented in 2011, in terms of the competitive environment, with many small players, and the largest ones commanding shares of around 5% only. Of this large group of players, MCM Klosterfrau Vertriebsgesellschaft mbH is the leader; the only company achieving over 10% value share in 2011. The company’s leadership is thanks to a good number of herbal brands, led by Ricola medicated confectionery.

PROSPECTS

  • Over the forecast period, retail value sales of herbal/traditional products are expected to see further annual decline in constant terms. These products will continue to suffer from the stiff competition from homoeopathic products and other areas such as fortified/functional packaged food and beverages, low consumer demand in general as well as the low marketing and sales related activities of the leading manufacturers.

CATEGORY DATA

  • Table 61 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 62 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 63 Herbal/Traditional Products Company Shares 2007-2011
  • Table 64 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 65 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 66 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Germany - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care enjoyed the seventh successive year of positive value growth in Germany (in current terms) and saw sales grow by almost 2% to €445 million in 2011. The trend towards self-medication continued to strengthen, and was fuelled by many factors. An increasing number of consumers consider problems of this nature to be less severe and thus more appropriately treated without visiting a doctor (and a pharmacist can also be called on to provide advice), while for others there are time constraints, and a significant number of people may feel embarrassment about their skin condition.

SWITCHES

COMPETITIVE LANDSCAPE

  • In an overall relatively fragmented category, in which many different players are active, two companies achieved double-digit shares of total value sales, namely Novartis Consumer Health GmbH and Bayer Vital GmbH. Both had very well-known and popular products in their portfolios, for example Fenistil and Lamisil (Novartis) as well as Canesten (Bayer). In addition, there were another almost 20 players with a share of between 1% and 6%.

PROSPECTS

  • Over the forecast period, retail value sales of medicated skin care products in Germany are expected to grow by just a small percentage annually in constant terms. In 2016, sales are predicted to reach €451 million, up just €6 million compared to 2011 (also in constant terms). Many of the positive factors in favour of the category’s development are expected to remain in place, although their impact will be somewhat weaker.

CATEGORY DATA

  • Table 67 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 68 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 69 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 70 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 71 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 72 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 73 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Germany - Category Analysis

HEADLINES

TRENDS

  • NRT smoking cessation aids declined in Germany in 2011 for the third year in a row. Several factors continued to be responsible for this negative development in terms of retail value sales. Due to the shrinking number of smokers in Germany, the target group is getting smaller, with many consumers try to quit using alternative means (prescription drugs or herbal products for example) or not using any nicotine replacement related method at all. In addition, OTC sales could further decline, if, as it is heavily lobbied, smoking cessation aids were to become paid for by the health insurance system through prescriptions.

SWITCHES

COMPETITIVE LANDSCAPE

  • The top three players in the category in Germany in 2011 remained Johnson & Johnson GmbH with Nicorette, Novartis Consumer Health GmbH with Nicotinell and GlaxoSmithKline GmbH & Co KG with Niquitin, and they distributed almost the entire market among themselves. Thereby, Nicorette continued to be the leading brand in the category, with its inhalator a key success on the German market, giving the company and brand an innovative image.

PROSPECTS

  • Over the forecast period, retail value sales of NRT smoking cessation aids are expected to decline by around 3% annually in constant terms. In 2016 therefore, total value sales of the category are predicted to reach €33 million, down €5 million compared to 2011. The main reason for this unfavourable development is the fact that a large proportion of smokers, who were willing to quit, have already done so following the smoking bans in 2007 and 2008.

CATEGORY INDICATORS

  • Table 74 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 75 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 76 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 77 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 78 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 79 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 80 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 81 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

OTC Triptans in Germany - Category Analysis

HEADLINES

TRENDS

  • 2011 saw the introduction of a second product in the category in Germany; Dolortriptan, with the active ingredient almotriptan, was introduced by Johnson & Johnson GmbH. This launch and the continued growth of Formigran (GlaxoSmithKline GmbH & Co KG) were responsible for a considerable further increase of category value sales in Germany in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, Formigran from GlaxoSmithKline GmbH & Co KG and Dolortritpan from Johnson & Johnson GmbH were the only brands and companies present in OTC triptans in Germany. Due to its launch around five years earlier, Formigran was by far the larger brand than more recently-launched Dolortriptan.

PROSPECTS

  • Retail value sales of triptans are expected to increase to a considerable degree over the forecast period. 2016 sales in constant value terms are predicted to reach €24 million, over three times as high as 2011 sales. Therefore, although the average growth rates appear to be very impressive, the growth started from a small base, and in absolute terms, especially compared to other OTC categories, they are still high, but somewhat less impressive.

CATEGORY DATA

  • Table 82 Sales of OTC Triptans: Value 2006-2011
  • Table 83 Sales of OTC Triptans: % Value Growth 2006-2011
  • Table 84 OTC Triptans Company Shares by Value 2007-2011
  • Table 85 OTC Triptans Brand Shares by Value 2008-2011
  • Table 86 Forecast Sales of OTC Triptans: Value 2011-2016
  • Table 87 Forecast Sales of OTC Triptans: % Value Growth 2011-2016

Sports Nutrition in Germany - Category Analysis

HEADLINES

TRENDS

  • Retail value sales of sports nutrition continued to increase in Germany in 2011, although growth has started to stabilise. In line with the very strong health and wellness trend, the number of gym goers, the main target group for sports nutrition, continued to increase in Germany. In addition, marathons and long distance running, rock climbing, mountain biking, bodybuilding and other types of extreme sports remained growth categories in Germany, which require a special diet and sports nutrition to maintain maximum fitness. This expansion of the consumer base supports the increased consumer demand for sports nutrition in the country.

COMPETITIVE LANDSCAPE

  • Sports nutrition is a highly fragmented area in Germany with a multitude of local and foreign brands. Of the various companies, there were four players with retail value sales shares of over 10% in Germany in 2011, namely Atlantic Multipower Germany GmbH & Co oHG, Genuport Trade AG, Weider Germany GmbH and INKO Internationale Handelskontor GmbH. Within their target group, all these players and their products and brands have high awareness, good reputation as well as rather loyal followers. A good number of product variants within sports nutrition also allows these players to accrue more significant shares than their numerous competitors.

PROSPECTS

  • Over the forecast period, retail value sales of sports nutrition are expected to grow to a small degree annually in constant terms, so that by 2016 sales will reach €107 million, up €8.5 million compared to 2011. Increased health consciousness of the population, increased gym membership and the growth in different types of extreme sports will support a higher consumer demand for these products.

CATEGORY DATA

  • Table 88 Sales of Sports Nutrition: Value 2006-2011
  • Table 89 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 90 Sports Nutrition Company Shares 2007-2011
  • Table 91 Sports Nutrition Brand Shares 2008-2011
  • Table 92 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 93 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Germany - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements declined in 2010 by 2% and in 2011 by 1% in current retail value terms, following more than 10 years of, albeit small, positive annual growth in Germany. The category faces strong, increasing competition from other products, especially naturally healthy and fortified/functional products on the one hand, and is under pressure due to frequent unfavourable media reports, questioning the effectiveness or even safety of its many subcategories on the other hand.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • The category of vitamins and dietary supplements in Germany continued to be rather fragmented overall in 2011, with a huge number of companies present with relatively small average shares of overall retail value sales. Largest players, with well-known and well-liked products and brands, included GlaxoSmithKline GmbH & Co KG, MCM Klosterfrau Vertriebsgesellschaft mbH, as well as private label players Rossmann, dm-drogerie markt, Aldi Süd and Aldi Nord.

PROSPECTS

  • Over the forecast period, retail value sales of vitamins and dietary supplements in Germany are expected to decline by 2% annually on average in constant terms. The above-discussed factors limiting the category’s development in Germany will continue to be stronger than those supporting growth.

CATEGORY DATA

  • Table 94 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 95 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 96 Dietary Supplements by Positioning 2006-2011
  • Table 97 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 98 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 99 Vitamins Brand Shares by Value 2008-2011
  • Table 100 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 101 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 102 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016
  • Summary 38 Dietary Supplements: Brand Ranking by Positioning 2011

Weight Management in Germany - Category Analysis

HEADLINES

TRENDS

  • Weight management products continued to benefit growing obesity and overweight problems in Germany towards 2011, while at same time also face threats from alternative products. Challenges facing weight management come from activities of manufacturers of branded and private label packaged food products focusing on health and wellness, for example in the form of many new reduced fat products. In addition, the category had to deal with negative media reports once again, indicating that most of the products offered would be ineffective or even harmful to their users. Nonetheless, overall value sales still managed to grow in 2011, primarily driven by positive sales increase from meal replacement slimming products and OTC obesity.

COMPETITIVE LANDSCAPE

  • The largest players in weight management products in Germany in 2011 are Amway GmbH and Herbalife Deutschland GmbH. Both direct sellers continued to be particularly successful in weight management due to their large number of sellers, who are able to give more advice to consumers than for example pharmacists. Most of the sellers have used the products themselves and promote them to friends and family so clearly there is more trust involved compared to purchasing a product in a pharmacy, drugstore or over the internet.

PROSPECTS

  • Over the forecast period, retail value sales of weight management products in Germany are expected to show stagnant performance in the forecast period. Slimming teas, weight loss supplements and other slimming products will continue to see a decline due to falling consumer demand, which is eroded by stiff competition from health and wellness related packaged food products. Meanwhile, meal replacement slimming is likely to fare better than other formats, thanks to its seen more as a ‘food’.

CATEGORY DATA

  • Table 103 Sales of Weight Management: Value 2006-2011
  • Table 104 Sales of Weight Management: % Value Growth 2006-2011
  • Table 105 Weight Management Company Shares 2007-2011
  • Table 106 Weight Management Brand Shares 2008-2011
  • Table 107 Forecast Sales of Weight Management: Value 2011-2016
  • Table 108 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Germany - Category Analysis

HEADLINES

TRENDS

  • Retail value sales of OTC wound care products increased in Germany in 2011 for the third year in a row to €138 million. Despite ongoing pressure from private label, due to the fact that the category’s products are considered by many consumers to be commodities rather than medical products, it was able to grow in Germany for several reasons, including increased volume demand, higher prices for high-end products and also fewer prescriptions of wound care products.

COMPETITIVE LANDSCAPE

  • Two companies continued to be responsible for the bulk of share of the category’s overall retail value sales in Germany in 2011, namely Beiersdorf AG and Paul Hartmann AG, with 39% and 21%, respectively, thus having a combined three fifths share of the category total. Their brands and products are household names in Germany with very high awareness on the one hand and excellent reputation and considerable loyalty on the other hand.

PROSPECTS

  • OTC wound care in Germany is expected to grow to a small degree annually in constant value terms over the forecast period. 2016 value sales thereby are predicted to exceed €140 million, up just €3 million compared to 2011. Continued growth of the category will be underpinned by sticking plasters/adhesive bandages and gauze, tape and other wound care products. First aid kits is expected to register negative growth, partly due to the low-value products that will continue to flood the market and partly due to the small number of new cars on the road due to a difficult economic climate in the country.

CATEGORY DATA

  • Table 109 Sales of Wound Care by Category: Value 2006-2011
  • Table 110 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 111 Wound Care Company Shares by Value 2007-2011
  • Table 112 Wound Care Brand Shares by Value 2008-2011
  • Table 113 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 114 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Artichoke
            • Hawthorn
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Silica
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!